NYSE - Delayed Quote • USD
Veeva Systems Inc. (VEEV)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 6:09 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 26 | 23 |
| Avg. Estimate | 1.42 | 1.52 | 6.15 | 6.81 |
| Low Estimate | 1.42 | 1.48 | 6.05 | 6.23 |
| High Estimate | 1.44 | 1.57 | 6.19 | 7.09 |
| Year Ago EPS | 0.91 | 1.21 | 4.84 | 6.15 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 27 | 24 |
| Avg. Estimate | 641.94M | 675.3M | 2.73B | 3.11B |
| Low Estimate | 640.13M | 665.5M | 2.7B | 3.04B |
| High Estimate | 644.22M | 680.88M | 2.74B | 3.17B |
| Year Ago Sales | -- | -- | 2.36B | 2.73B |
| Sales Growth (year/est) | -- | -- | 15.60% | 13.70% |
Earnings History
| CURRENCY IN USD | 4/30/2023 | 7/31/2023 | 10/31/2023 | 1/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.79 | 1.13 | 1.3 | 1.3 |
| EPS Actual | 0.91 | 1.21 | 1.34 | 1.38 |
| Difference | 0.12 | 0.08 | 0.04 | 0.08 |
| Surprise % | 15.20% | 7.10% | 3.10% | 6.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.42 | 1.52 | 6.15 | 6.81 |
| 7 Days Ago | 1.42 | 1.51 | 6.15 | 6.81 |
| 30 Days Ago | 1.42 | 1.51 | 6.15 | 6.81 |
| 60 Days Ago | 1.27 | 1.38 | 5.57 | 6.27 |
| 90 Days Ago | 1.27 | 1.38 | 5.57 | 6.27 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | VEEV | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 56.00% | -- | -- | 2.60% |
| Next Qtr. | 25.60% | -- | -- | 13.40% |
| Current Year | 27.10% | -- | -- | 5.20% |
| Next Year | 10.70% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 13.95% | -- | -- | 11.11% |
| Past 5 Years (per annum) | 22.47% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 4/2/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 3/27/2024 |
| Maintains | Raymond James: Outperform to Outperform | 3/26/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 3/13/2024 |
| Maintains | Morgan Stanley: Underweight to Underweight | 3/12/2024 |
| Maintains | Keybanc: Overweight to Overweight | 3/5/2024 |
Related Tickers
DOCS Doximity, Inc.
23.59
-1.34%
PGNY Progyny, Inc.
32.50
-0.31%
TDOC Teladoc Health, Inc.
13.33
-2.91%
TXG 10x Genomics, Inc.
26.90
-2.25%
GEHC GE HealthCare Technologies Inc.
85.95
-0.89%
SDGR Schrödinger, Inc.
23.34
-2.91%
HQY HealthEquity, Inc.
79.04
-0.20%
EVH Evolent Health, Inc.
28.32
-3.21%
CERT Certara, Inc.
16.30
-0.91%
SOLV Solventum Corporation
61.83
-2.69%